このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Robot-Assisted Versus Free-Hand CT-Guided Flexible Guidewire Localization of Pulmonary Nodules

2026年11月7日 更新者:Peking University Third Hospital

A Prospective Randomized Controlled Study of Robot-Assisted Versus Conventional Free-Hand CT-Guided Preoperative Flexible Guidewire Localization of Pulmonary Nodules

Small pulmonary nodules can be difficult to identify during thoracoscopic surgery. CT-guided flexible guidewire localization helps surgeons locate these nodules before resection. This study compares robot-assisted and conventional free-hand localization at Peking University Third Hospital. Sixty adults who require preoperative localization will be randomly assigned to one of two groups, with 30 participants in each group. Both groups will use the same type of flexible guidewire localization needle. The primary objective is to compare radiation exposure measured by dose-length product. The study will also assess puncture performance, localization accuracy, procedure duration, CT scan count, and procedure-related complications.

調査の概要

詳細な説明

This investigator-initiated, prospective, single-center, randomized, parallel-group study compares robot-assisted and conventional free-hand CT-guided flexible guidewire localization before thoracoscopic pulmonary nodule resection. Written informed consent is obtained before enrollment.

Participants undergo a localization difficulty assessment. A computer-generated sequence assigns participants in a 1:1 ratio within low- and high-difficulty strata using block randomization. Both groups use the same type of flexible guidewire localization needle. In the robot-assisted group, CT images are used for three-dimensional reconstruction and trajectory planning. The physician confirms the target, entry point, angle, and depth, and inserts the needle with robotic trajectory guidance. Repeat CT confirms the needle position, and the guidewire is deployed after the planned target region has been reached. Post-localization CT assesses guidewire position and complications.

The procedure is open-label. The protocol specifies blinded assessment of post-localization CT images by two independent imaging physicians. Planned and actual puncture angles and depths, and the distance between the planned target and actual needle tip, are also recorded in the robot-assisted group. Conversion to free-hand localization is permitted when required for participant safety because of robotic system failure or failed registration, and the reason is recorded.

Continuous variables are summarized as means and standard deviations or medians and interquartile ranges, as appropriate. Between-group comparisons use the independent-samples t test or Mann-Whitney U test. Categorical variables are compared using the chi-square test or Fisher exact test.

研究の種類

介入

入学 (推定)

60

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究連絡先

研究場所

    • Beijing Municipality
      • Beijing、Beijing Municipality、中国、100191
        • 募集
        • Peking University Third Hospital
        • コンタクト:

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

18年~80年 (大人、高齢者)

健康ボランティアの受け入れ

いいえ

受講資格のある性別

全て

説明

Inclusion Criteria:

  • Age 18 to 80 years.
  • A pulmonary nodule identified on preoperative high-resolution chest CT, with planned thoracoscopic wedge resection or segmentectomy.
  • Maximum target nodule diameter of 20 mm or less.
  • A pure ground-glass, part-solid (mixed ground-glass), or small solid nodule.
  • A nodule considered difficult to identify by intraoperative inspection or palpation and requiring preoperative CT-guided localization.
  • Ability to tolerate percutaneous pulmonary localization and subsequent video-assisted thoracoscopic surgery.
  • Voluntary participation and written informed consent from the participant or a legally authorized representative.

Exclusion Criteria:

  • Maximum target nodule diameter greater than 20 mm, or no need for preoperative localization in the investigator's judgment.
  • No safe puncture trajectory that avoids major vessels, the heart, mediastinum, severe bullous disease, or other important structures.
  • Severe pulmonary dysfunction that precludes percutaneous pulmonary puncture or thoracoscopic surgery.
  • Coagulation dysfunction or inability to interrupt anticoagulant or antiplatelet treatment according to clinical standards.
  • Clinically significant pneumothorax, pleural effusion, active infection, or another condition affecting safety assessment before localization.
  • Pregnancy or breastfeeding.
  • Inability to cooperate with positioning, breath-holding, or CT scanning.
  • Severe ipsilateral pleural adhesions, previous thoracic surgery, or previous radiotherapy considered to compromise localization safety.
  • Any other condition making participation unsuitable in the investigator's judgment.

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:他の
  • 割り当て:ランダム化
  • 介入モデル:並列代入
  • マスキング:独身

武器と介入

参加者グループ / アーム
介入・治療
実験的:Robot-Assisted CT-Guided Localization

Participants undergo robot-assisted CT-guided flexible guidewire localization before thoracoscopic resection. The uInterv C550-A system is used for CT-based reconstruction and trajectory planning. The physician confirms the target, entry point, angle, and depth and inserts the needle with robotic trajectory guidance. CT confirms satisfactory needle-tip placement before guidewire deployment. Final CT assesses guidewire position and complications. Both arms use the same type of flexible guidewire localization needle.

The uInterv C550-A robotic puncture navigation and positioning system is used for CT-guided preoperative flexible guidewire localization of pulmonary nodules. CT images are used for three-dimensional reconstruction and trajectory planning. The physician confirms the target, skin entry point, puncture angle, and depth, and inserts the needle with robotic trajectory guidance. CT confirms satisfactory needle-tip placement before the flexible guidewire is deployed. A final CT scan assesses guidewire position and procedure-related complications. The same type of flexible guidewire localization needle is used in both groups.

他の名前:
  • uInterv C550-A
アクティブコンパレータ:Conventional Free-Hand CT-Guided Localization

Participants undergo conventional free-hand CT-guided flexible guidewire localization before thoracoscopic resection. The physician selects the skin entry point and trajectory on CT images, inserts the localization needle under local anesthesia, and adjusts the needle as needed. CT confirms satisfactory needle-tip placement before guidewire deployment. Final CT assesses guidewire position and complications. Both arms use the same type of flexible guidewire localization needle.

Percutaneous placement of a flexible guidewire localization needle using conventional manual trajectory planning and CT guidance before thoracoscopic resection. The physician inserts and adjusts the needle as needed. CT confirms satisfactory needle-tip placement before guidewire deployment, followed by final CT assessment.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Total Dose-Length Product
時間枠:During the localization procedure, from the first CT scan to completion of the final CT scan after guidewire deployment

Total dose-length product (DLP), measured in mGy·cm, summed across all localization-related CT acquisitions, including the initial planning CT, CT acquisitions during needle placement, and the final post-deployment CT.

During the localization procedure, from the first CT scan to completion of the final CT scan after guidewire deployment

二次結果の測定

結果測定
メジャーの説明
時間枠
First-Attempt Puncture Success Rate
時間枠:During the localization procedure

Percentage of participants with satisfactory needle-tip placement on the first puncture attempt without subsequent needle adjustment.

During the localization procedure
Technical Localization Success Rate
時間枠:From guidewire localization through completion of the subsequent thoracoscopic resection

Percentage of participants in whom flexible guidewire localization enables intraoperative identification and resection of the target pulmonary nodule during thoracoscopic surgery.

From guidewire localization through completion of the subsequent thoracoscopic resection
Localization Deviation
時間枠:During localization, on the CT scan confirming final needle-tip position before guidewire deployment

Distance in millimeters between the planned target point and the actual needle-tip position, measured on CT after needle placement.

During localization, on the CT scan confirming final needle-tip position before guidewire deployment
Number of Needle Adjustments
時間枠:During the localization procedure

Number of adjustments to needle position after the initial needle insertion during CT-guided localization.

During the localization procedure
Number of Pleural Punctures
時間枠:During the localization procedure

Number of needle punctures through the pleura during CT-guided localization.

During the localization procedure
Localization Procedure Duration
時間枠:During the localization procedure, from the first CT scan through completion of the final post-deployment CT scan

Elapsed time in minutes from the start of the first localization-related CT scan to completion of the final CT scan after flexible guidewire deployment.

During the localization procedure, from the first CT scan through completion of the final post-deployment CT scan
Number of CT Acquisitions
時間枠:During the localization procedure

Total number of CT acquisitions performed for localization, including the initial planning CT, scans during needle placement, and the final CT after guidewire deployment.

During the localization procedure
Pneumothorax Rate
時間枠:From localization through 2 months after localization

Percentage of participants with localization-related pneumothorax, assessed on post-localization CT and during follow-up.

From localization through 2 months after localization
Intrapulmonary Hemorrhage Rate
時間枠:From localization through 2 months after localization

Percentage of participants with localization-related intrapulmonary hemorrhage, assessed on post-localization CT and during follow-up.

From localization through 2 months after localization
Guidewire Dislodgement or Migration Rate
時間枠:From guidewire deployment through the subsequent thoracoscopic surgery; safety follow-up through 2 months after localization

Percentage of participants with dislodgement or migration of the localization guidewire after deployment, assessed on CT and during subsequent thoracoscopic surgery. Events are recorded during the 2-month safety follow-up; the guidewire is used for preoperative localization and is not intended to remain in place throughout follow-up.

From guidewire deployment through the subsequent thoracoscopic surgery; safety follow-up through 2 months after localization

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

捜査官

  • 主任研究者:Fuxin Guo、Peking University Third Hospital

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (実際)

2026年10月28日

一次修了 (推定)

2027年2月1日

研究の完了 (推定)

2027年4月1日

試験登録日

最初に提出

2026年11月7日

QC基準を満たした最初の提出物

2026年11月7日

最初の投稿 (実際)

2026年11月13日

学習記録の更新

投稿された最後の更新 (実際)

2026年11月13日

QC基準を満たした最後の更新が送信されました

2026年11月7日

最終確認日

2026年11月1日

詳しくは

本研究に関する用語

その他の研究ID番号

  • M20260645

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

いいえ

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する